ACTRN12610000803099
Not yet recruiting
未知
The Effect of Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) on Overall Survival of Patients with Relapsed Diffuse Large B-Cell Lymphoma Post-Autologous Stem Cell Transplant
Haematology and Oncology Clinics (HOCA) Research Centre0 sites150 target enrollmentSeptember 27, 2010
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Haematology and Oncology Clinics (HOCA) Research Centre
- Enrollment
- 150
- Status
- Not yet recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with histologically\-confirmed DLBCL
- •Must have received CHOP (CHOP 14, CHOP 21\) or R\-CHOP (R\-CHOP 14, R\-CHOP 21\) chemotherapy as first\-line therapy
- •Must have received an auto\-SCT transplant after relapse
Exclusion Criteria
- •Patients with low\-grade lymphoma at presentation or relapse.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Mechanism Investigation of R-CHOP Regimen or Tucidinostat Plus R-CHOP (CR-CHOP) Regimen in the Treatment of BCL2/MYC Protein Double Expressor LymphomaDiffuse Large B Cell Lymphoma (DLBCL)Double Expressor LymphomaNCT06652152Ruijin Hospital400
Completed
Phase 2
Phase II randomised study of fludarabine/cyclophosphamide combination with or without rituximab in patients with untreated mantle cell lymphomaISRCTN81133184niversity College London (UK)151
Recruiting
Not Applicable
Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous NephropathyMembranous Nephropathy - PLA2R InducedNCT05679336St. Petersburg State Pavlov Medical University40
Unknown
Phase 3
R-CHOP Versus R-CDOP as First-line Treatment for Elderly Patients With Diffuse Large-B-cell LymphomaLymphoma, Large B-Cell, DiffuseNCT02428751Wenqi Jiang216
Completed
Phase 2
A phase II study of the combination of Rituximab, Mitoxantrone, Etoposide, and Prednisolone for relapsed elderly patients with diffuse large B-cell lymphoma (R-MEP07)Diffuse large B-cell lymphomaJPRN-UMIN000001050Clinical Hematology Study Group of National Hospital Organization (CHSG-NHO)40